SCTX

NASDAQ Healthcare

Scribe Therapeutics Inc. - Common Stock

Biotechnology

Scribe Therapeutics Inc. operates as a clinical-stage biotechnology company, focuses on research and developing genetic medicines using CRISPR-based tools to address the root cause of diseases, with a primary focus on cardiometabolic conditions in the United States. The company offers STX-1150 designed to be a single-course in vivo epigenetic silencing treatment targeting the PCSK9 gene; STX-1200 is CRISPR-based gene editing program that aims to offer a permanent solution for patients with elevated Lp(a); and STX-1400 is designed to target and remove the transcriptional start site of the APOC3 gene and strongly reduce mRNA expression. It uses CRISPR-based platforms, such as ELXR, designed for precise, durable epigenetic silencing of genes without changing the underlying DNA sequence; and XE, designed to support specific and efficient gene editing. The company was incorporated in 2017 and is headquartered in Alameda, California.

�� 市场数据

价格	$21.19
成交量	117,725
市值	399.74M
RSI（14日）	56.5
52周最高	$26.50
52周最低	$17.31
Price / Book	-0.33

在Yahoo Finance查看 →

🎯 投资策略评分

SCTX 在各投资策略中的评分。分数越高，越符合该策略目标。

💰 Dividend Daddy 30/100

高股息率 + 低波动性

🚀 Moon Shot 9/100

高增长潜力（高贝塔 + 超卖）

🔪 Falling Knife 56/100

逆向投资（超卖 + 低于移动均线）

🎈 Over-Hyped 52/100

超买股票（潜在做空标的）

🐋 Institutional Whale 10/100

大盘、机构级别股票

🔍 策略解读

最佳匹配： 🔪 Falling Knife (56/100) — 此策略逆向投资（超卖 + 低于移动均线）.

评分最低的策略： 🚀 Moon Shot (9/100). 单一评分不构成买入或卖出信号 — 请结合多种视角综合判断。了解如何解读这些评分 →

📚 了解更多

本页指标

教育文章

网站资源

在文本中查找 SCTX in your text

粘贴任何文章、记录或帖子 — 工具将提取 SCTX 以及每一个其他隐藏的股票代码。

试试股票代码提取器 →

免责声明：本数据仅供教育和娱乐用途，不构成金融建议。市场数据可能存在延迟。在做出投资决策之前，请始终进行自己的研究。
数据最后更新： 2026-08-17.